RE: Ironic!10 Mar 2023 10:29
Looks pretty ok to me.
To quote Gerry's slide from the Investor Q&A:
Board Outlook - Significant Growth for 2022
Stongest prderbook the company has ever had going into H2
Roll out of scientific and micro-engineering design business
Platform in Human and Environmental Health real-time moniroting
Further expansion of revenues through multiple strategic partners
Who really knows what Kingfield are bringing to the party and potentially the Chinese Partner
Oldish news but...
Microsaic Systems plc announced that Kingfield Electronics Limited has appointed Microsaic as an Authorised Partner for front-end research, development, and engineering product development in scientific instrumentation and micro-engineering adding these complementary services to its existing offering of fully integrated turnkey solutions, box build, printed circuit board assembly, commissioning, final test, service, retrofit and world-wide shipping logistics. This new partnership represents a further opportunity for Microsaic to provide additional services leveraging its considerable expertise in high quality technical design, engineering and solutions delivery, as it continues to diversify its income streams.
Microsaic Systems plc announced it has signed an agreement with Jiangsu Henzhihe Technologies Co. Ltd. to support the Company's relationship with the Chinese distributor (the "Distributor"), with whom the Company announced a signed Heads of Terms for its micro-engineered MS technology (per the RNS dated 4 May 2021). Under the agreement, HZH will provide integration and service support for Microsaic's operations in China.
HZH will act as the manufacturer, integrator, and service centre in support of distribution and prospective OEM partnerships in China. HZH is a recently incorporated entity whose directors have a long history of working with MS in China and manufacturing other analytical devices, and in active pharmaceutical ingredients ("API"). Their relationships include large analytical instrumentation and pharmaceutical companies.
HZH and Microsaic will collaborate with distribution partners to access and service other substantial growth opportunities in the Chinese market.